JP2001527581A5 - - Google Patents

Download PDF

Info

Publication number
JP2001527581A5
JP2001527581A5 JP1999518155A JP51815599A JP2001527581A5 JP 2001527581 A5 JP2001527581 A5 JP 2001527581A5 JP 1999518155 A JP1999518155 A JP 1999518155A JP 51815599 A JP51815599 A JP 51815599A JP 2001527581 A5 JP2001527581 A5 JP 2001527581A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999518155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001527581A (ja
Filing date
Publication date
Priority claimed from US09/154,287 external-priority patent/US20020012694A1/en
Application filed filed Critical
Publication of JP2001527581A publication Critical patent/JP2001527581A/ja
Publication of JP2001527581A5 publication Critical patent/JP2001527581A5/ja
Pending legal-status Critical Current

Links

JP51815599A 1997-09-17 1998-09-17 メントの経皮投与 Pending JP2001527581A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5930197P 1997-09-17 1997-09-17
US60/059,301 1997-09-17
US09/154,287 US20020012694A1 (en) 1997-09-17 1998-09-16 Transdermal administration of ment
US09/154,287 1998-09-16
PCT/US1998/019399 WO1999013812A1 (en) 1997-09-17 1998-09-17 Transdermal administration of ment

Publications (2)

Publication Number Publication Date
JP2001527581A JP2001527581A (ja) 2001-12-25
JP2001527581A5 true JP2001527581A5 (https=) 2005-09-08

Family

ID=26738606

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51815599A Pending JP2001527581A (ja) 1997-09-17 1998-09-17 メントの経皮投与

Country Status (6)

Country Link
US (2) US20020012694A1 (https=)
EP (1) EP0941039A4 (https=)
JP (1) JP2001527581A (https=)
BR (1) BR9806213A (https=)
CA (1) CA2270177C (https=)
WO (1) WO1999013812A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100452972B1 (ko) 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
WO2003068314A1 (en) * 2002-02-15 2003-08-21 Pantarhei Bioscience B.V. Pulmonary administration of 6-alpha-alkylated testosterone derivatives for androgen replacement therapy
WO2004011663A2 (de) * 2002-07-24 2004-02-05 Schering Aktiengesellschaft Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US7879357B2 (en) * 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7056332B2 (en) * 2003-07-24 2006-06-06 Materials Evolution And Development Usa, Inc. Nucleic acid biomaterials and methods of formation and use
US20070231373A1 (en) * 2004-04-28 2007-10-04 Hunter-Fleming Limited Transdermal Steriod for Formulation
CA2647809C (en) 2006-03-24 2016-08-16 Auxilium International Holdings, Inc. Stabilized compositions containing alkaline labile drugs
EP2010366B1 (en) 2006-03-24 2017-03-22 Auxilium International Holdings, Inc. Process for the preparation of a hot-melt extruded laminate
US20070243714A1 (en) * 2006-04-18 2007-10-18 Applied Materials, Inc. Method of controlling silicon-containing polymer build up during etching by using a periodic cleaning step
AU2010203373B2 (en) 2009-01-12 2013-08-01 University Of Massachusetts Lowell Polyisobutylene-based polyurethanes
EP2467174B1 (en) * 2009-08-21 2018-09-26 Cardiac Pacemakers, Inc. Crosslinkable polyisobutylene-based polymers and medical devices containing the same
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US9484123B2 (en) 2011-09-16 2016-11-01 Prc-Desoto International, Inc. Conductive sealant compositions
EP2922888B1 (en) 2012-11-21 2021-08-18 The University of Massachusetts High strength polyisobutylene polyurethanes
EP3592786B1 (en) 2017-03-07 2023-05-10 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
US10835638B2 (en) 2017-08-17 2020-11-17 Cardiac Pacemakers, Inc. Photocrosslinked polymers for enhanced durability
WO2019143629A1 (en) 2018-01-17 2019-07-25 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP0500287B1 (en) * 1991-02-20 1995-04-26 Hitachi, Ltd. Catalyzer control apparatus
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
WO1994023707A1 (de) * 1993-04-20 1994-10-27 Hexal Pharma Gmbh Wirkstoffplaster
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Similar Documents

Publication Publication Date Title
JP2000509942A5 (https=)
JP2000509912A5 (https=)
JP2000510751A5 (https=)
JP2000509635A5 (https=)
JP2000509637A5 (https=)
JP2002502379A5 (https=)
JP2002501646A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2001525063A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510969A5 (https=)
JP2000510247A5 (https=)
JP2000508836A5 (https=)
JP2000508102A5 (https=)
JP2000509818A5 (https=)
JP2000509520A5 (https=)